Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0663B (Etoricoxib/Tizanidine) in Acute Low Back Pain
NCT01979510Phase 3Withdrawn
- Sponsor
- Merck & Co.
- Start
- Nov 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of etoricoxib + tizanidine in acute low back pain, sponsored by Merck & Co.. Planned start Nov 2013; status: withdrawn.
02
Drugs
etoricoxib + tizanidine
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT01979510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979510.